<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864877</url>
  </required_header>
  <id_info>
    <org_study_id>D355 - 001</org_study_id>
    <nct_id>NCT00864877</nct_id>
  </id_info>
  <brief_title>Comparison of Biodegradable &amp; Metal Plates for Fixing Ankle Fracture</brief_title>
  <official_title>A Randomised, Prospective Clinical Investigation to Compare Post-Operative Fracture Healing and Complication Rate After the Fixation of Ankle Fractures Using the Inion OTPS FreedomPlate Biodegradable Fixation System Versus Conventional Metal Screws and Plates.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inion Oy</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inion Oy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised, prospective clinical investigation to compare post-operative fracture healing&#xD;
      and complication rate after the fixation of ankle fractures using the Inion OTPS&#xD;
      FreedomPlateTM Biodegradable Fixation System versus conventional stainless steel metal screws&#xD;
      and plates.&#xD;
&#xD;
      The objectives of the investigation are&#xD;
&#xD;
        -  to compare post-operative fracture healing (union rates, time-to-union), and the&#xD;
           complication rates (hardware failure, infection) between the two Plating Systems&#xD;
           (biodegradable INION OTPS FreedomPlateTM vs. Stainless Steel 3.5 Reconstruction or DCP&#xD;
           plate, or 1/3 Semitubular plates) at the clinical setting of Ankle fractures&#xD;
&#xD;
        -  to study the safety of the clinical application of the biodegradable plating system of&#xD;
           Inion OTPS FreedomPlateTM at the acute Ankle fracture setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>The functional performance will be primarily determined by the Olerud and Molander Ankle Score</measure>
    <time_frame>at 2, 6 and 12 weeks, and 12 and 24 months post-operatively</time_frame>
  </primary_outcome>
  <condition>Distal Fibular Fracture</condition>
  <condition>Bimalleolar Fracture</condition>
  <condition>Trimalleolar Fracture</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>biodegradable fixation system (Inion OTPS FreedomPlateTM)</intervention_name>
    <other_name>Inion OTPS(tm) FreedomPlate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is willing and able to understand, sign and date the study-specific,&#xD;
             Institutional Review Board/Ethics Committee approved patient informed consent and&#xD;
             applicable privacy regulations.&#xD;
&#xD;
          2. Patient must require surgical treatment of a ankle fracture, with a distal fibular&#xD;
             (i.e., lateral malleolus) fracture (isolated, closed, unilateral, non-comminuted)&#xD;
             including either instable/dislocated Weber class B or any Weber class C fracture that&#xD;
             cannot be anatomically reconstructed accurately without open procedure, or bimalleolar&#xD;
             fracture with lateral malleolus fracture (as described above) and medial malleolus&#xD;
             fracture (closed, unilateral, non-comminuted), or trimalleolar fracture with lateral&#xD;
             and medial malleolus fractures as described above and posterior malleolus fracture&#xD;
             with less than Â¼ of the articular surface fractured&#xD;
&#xD;
          3. Fresh/acute fractures (seen within seventy-two hours of the injury)&#xD;
&#xD;
          4. Aged between 18 to 60 years&#xD;
&#xD;
          5. Skeletally mature&#xD;
&#xD;
          6. Willingness to accept randomisation either to the test or control group&#xD;
&#xD;
          7. Willingness and ability to comply with all investigation procedures pre- and&#xD;
             post-operation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications of operative internal plate fixations&#xD;
&#xD;
          2. Contraindications for the Inion OTPS FreedomPlateTM Biodegradable Fixation System:&#xD;
&#xD;
               -  active or potential infection&#xD;
&#xD;
               -  patient's conditions, including limited blood supply, insufficient quantity or&#xD;
                  quality of bone, and where patient cooperation cannot be guaranteed (e.g.,&#xD;
                  alcoholism, drug abuse)&#xD;
&#xD;
               -  high-load bearing applications&#xD;
&#xD;
          3. Multiple trauma, head injury, bilateral lower extremity fractures, upper extremity&#xD;
             fractures&#xD;
&#xD;
          4. Any concomitant painful or disabling disease of the lower limb that would interfere&#xD;
             with evaluation of the affected ankle&#xD;
&#xD;
          5. Previous ankle fracture&#xD;
&#xD;
          6. Patients who most likely will not learn to walk with crutches (e.g., due to being&#xD;
             severely overweight)&#xD;
&#xD;
          7. Bone malignancy&#xD;
&#xD;
          8. Osteomyelitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Giannoudis, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leeds General Infirmary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <zip>LS13EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <study_first_submitted>March 18, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <last_update_submitted>March 18, 2009</last_update_submitted>
  <last_update_submitted_qc>March 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2009</last_update_posted>
  <keyword>retrospective</keyword>
  <keyword>comparison</keyword>
  <keyword>biodegradable</keyword>
  <keyword>implant</keyword>
  <keyword>ankle fracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Ankle Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

